Tylvalosin

Tylvalosin (Acetylisovaleryltylosin) is a broad-spectrum macrolide antibiotic with antibacterial and antiviral properties, effective against PRRSV infection. It induces apoptosis and possesses anti-inflammatory activity. Furthermore, Tylvalosin mitigates oxidative stress and acute lung injury through the suppression of NF-κB activation [1] [2].

O([C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(/C)=C/[C@H](CO[C@H]3[C@H](OC)[C@H](OC)[C@H](O)[C@@H](C)O3)[C@@H](CC)OC(=O)C[C@@H](OC(C)=O)[C@@H]2C)O[C@@H]1C)[C@H]4C[C@@](C)(O)[C@@H](OC(CC(C)C)=O)[C@H](C)O4